Ute van Goethem elected Vice President: New ways in the pharmaceutical industry!

Ute van Goethem elected Vice President: New ways in the pharmaceutical industry!

In a significant realignment, the forum of the researching pharmaceutical industry (FOPI) has now won an experienced manager as vice president with Mag. Ute van Goethe. This decision follows the appointment of Leif E. Moll as President of the Association. Van Goethem, who is currently managing director of ABBVIE in Austria, has an extensive international specialist knowledge from her previous position as a commercial director oncology in Europe. "Innovative pharmaceutical industry is a reliable partner when it comes to setting new standards in the treatment of serious diseases," she said, emphasizing the urgency that pharmaceutical innovations should quickly arrive at the patient. This information was reported by OTS

reinforcement of the management team

Together with her team, which also includes Vice President George Tousimis and Secretary General Astrid Jankowitsch, van Goethem will represent the association to the outside world. Your goal is to improve the framework conditions from research to reimbursement. "The current political situation gives us the opportunity to change the healthcare system for the better together with the other partners," she added. This shows not only the use of the FOPI to improve patient care, but also the commitment to a constructive dialogue and specific solutions.

In another area, doctors' reviews are becoming increasingly important, especially in the digital health landscape. The health portal jameda has implemented additional verification processes to ensure the authenticity of the patient reviews. This system comprises several stages, including confirmation of telephone numbers and appointments, so that the trustworthiness of the ratings is significantly increased. This is particularly relevant for patients who rely on reliable information in order to make well -founded decisions when choosing doctors.